Skip to Main Content

Paper Details

New filovirus disease classification and nomenclature.
Nat Rev Microbiol
64
2019
filovirus disease
Filoviridae, Filoviridae Infections, Hemorrhagic Fever, Ebola, Humans, World Health Organization
Author NameAffiliation
Jens H KuhnNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Takuya AdachiToshima Hospital
Neill K J AdhikariSunnybrook Health Sciences Centre and University of Toronto
Jos?? R ArribasHospital La Paz-Carlos III IdiPAZ
Ibrahima BahDonka Hospital
Daniel G Bausch
Nahid BhadeliaBoston University School of Medicine
Matthias BorchertRobert Koch Institute
Arne Broch BrantsaeterUniversity of Oslo
David M Brett-MajorF. Edward Hebert School of Medicine, Uniformed Services University
Timothy H BurgessF. Edward Hebert School of Medicine, Uniformed Services University
Daniel S ChertowNational Institutes of Health Clinical Center
Christopher G ChuteJohns Hopkins University
Theodore J CieslakUniversity of Nebraska Medical Center, College of Public Health
Robert ColebundersUniversity of Antwerp, Global Health Institute
Ian CrozierClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research supported by the National Cancer Institute
Richard T DaveyClinical Research Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Hilde De Clerck
Rafael DelgadoInstituto de Investigacion Hospital 12 de Octubre
Laura EvansNYU Langone Medical Center
Mosoka FallahNational Public Health Institute
William A Fischer
Tom E FletcherHealth Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool Institute of Translational Medicine and National Institute for Health Research
Robert A FowlerInstitute for Clinical Evaluative Sciences, Institute of Health Policy, University of Toronto
Thomas Gr??newald
Andrew HallKing's College London & King's Health Partners
Angela L HewlettUniversity of Nebraska Medical Center
Andy I M HoepelmanUniversity Medical Center Utrecht
Catherine F HoulihanUniversity College London
Giuseppe IppolitoIstituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" (National Institute for Infectious diseases "Lazzaro Spallanzani" - IRCCS)
Shevin T Jacob
Michael JacobsRoyal Free London NHS Foundation Trust
Robert Jakob
Frederique JacqueriozUniversity Hospitals of Geneva
Laurent KaiserGeneva Center for Emerging Viral Diseases
Andre C KalilUniversity of Nebraska Medical Center
Rashidatu Fouad KamaraMinistry of Health and Sanitation
Jimmy KapetshiInstitut National de Recherche Biomedicale
Hans-Dieter KlenkInstitute of Virology, Philipps University of Marburg
Gary P KobingerUniversite Laval
Mark G KortepeterUniversity of Nebraska Medical Center, College of Public Health
Colleen S KraftEmory University School of Medicine
Thomas KratzRobert Koch Institute
Henry Kyobe BosaCollege of Health Sciences, School of Public Health, Makerere University
Marta Lado
Fran??ois LamontagneUniversite de Sherbrooke Sherbrooke
Henry Clifford LaneDivision of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Leslie LobelSchool of Pharmacy, Center for Emerging Diseases, Ben Gurion University of the Negev
Julius J LutwamaUganda Virus Research Institute
George M LyonEmory University School of Medicine
  • 1 - 50

Datasets